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mortality in patients with end-stage renal disease. We evaluated the prevalence, association
factors, and outcomes of chest X-ray-detected aortic arch calcification (AoAC) in patients un-
dergoing peritoneal dialysis (PD).
Methods: We included 190 patients undergoing PD (mean age, 52.6  14.3 years) for whom
chest radiographs were available. AoAC revealed by chest X-ray was graded from 0 to 3 accord-
ing to an AoAC score (AoACS). Multiple regression analyses were used to determine the factors
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dialysis, Journal of the Formosan Meblood pressure, and history of CV disease, the association between AoAC grading and mortality
were assessed using the KaplaneMeier curve and Cox proportional hazard model.
Results: Age (p < 0.001), PD duration (pZ 0.004), history of CV disease (p < 0.001), and renal
Kt/V (pZ 0.031) were associated with AoACS. After a mean follow-up of 55.1  32.1 months,
patients with Grade 2 (p Z 0.011) or Grade 3 (p < 0.001) AoAC had higher all-cause mortality
than patients with Grade 0 AoAC. In addition, patients with Grades 2 and 3 AoAC had higher CV-
related mortality than those with Grades 0 and 1 AoAC (p Z 0.013). Grade 2 [hazard ratio
(HR) Z 2.736; 95% confidence interval (CI), 1.038e7.211; p Z 0.042] and Grade 3 AoAC
(HR Z 3.289; 95% CI, 1.156e9.359; p Z 0.026) remained associated with all-cause mortality
after adjustment. Similarly, Grades 2 and 3 AoAC (HR Z 36.05; 95% CI, 3.494e372;
p Z 0.026) significantly correlated with CV mortality after adjustment.
Conclusion: In patients undergoing PD, CXR-detected severe AoAC was an independent risk
factor for all-cause and CV mortalities.
Copyright ª 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Cardiovascular (CV) events have been amajor cause of death
in patients with end-stage renal disease (ESRD)1,2; the inci-
dence is 10 to 30 times higher than that of the general pop-
ulation.3 In addition to the traditional risk factors of CV
events, uremia-specific phenomena including vascular
calcification are also responsible for the higher incidence of
CV events in patients with ESRD.4 Vascular calcification,
which may involve arterial media, atherosclerotic plaques,
or cardiac valves,4 is highly prevalent in patients with ESRD
including younger age groups.5,6 The existence and extent of
vascular calcification are strong predictors of CV morbidity
and mortality in both patients undergoing hemodialysis (HD)
and those undergoing peritoneal dialysis (PD).7e13
In order to evaluate or quantify vascular calcification,
several imaging techniques such as electron beam
computed tomography (EBCT), multislice spiral CT (MSCT),
echocardiography, vascular ultrasound, and plain radiog-
raphy have been used. Among them, EBCT and MSCT are
still considered the gold standards for quantifying coronary
or aortic calcification.14 However, these methods are
expensive and expose the patients to high doses of radia-
tion and risks of cancer.15,16 Chest radiography (CXR),
comparatively, is an inexpensive test with lower radiation
exposure. Currently, it is a simple and useful tool to eval-
uate aortic arch calcification (AoAC); the presence or pro-
gression of AoAC has been shown to correlate with all-cause
and CV mortality in patients with ESRD,17 patients under-
going HD,18e20 and even in patients undergoing PD.13
The aim of this study was to evaluate the prevalence and
associated risk factors of CXR-detected AoAC in patients
undergoing PD because its clinical significance has not yet
been fully investigated. The prognostic value of CXR-
detected AoAC in long-term CV morbidity as well as all-
cause and CV mortalities was also analyzed.
Methods
Patients
In October 2006, 192 patients underwent PD for more than
3 months at the National Taiwan University Hospital. Amongu C-F, et al., Severe aortic arch
dical Association (2016), http://dthem, two patients were excluded from the study because
chest radiographs were unavailable or death occurred in
November 2006. Finally, 190 patients were enrolled and
were followed-up for 8 years. More than 75% patients
received continuous ambulatory PD, and all patients used
lactate-buffered dialysate. The study was approved by the
Institution Review Board of the hospital (number
200912054R) and was in adherence with the Declaration of
Helsinki.
AoAC revealed by CXR
The chest radiographs of patients between June and
August 2006 were evaluated. AoAC was assessed by a
specific scale developed in a previous study.21 Briefly, a
scale, divided into 16 circumferences, was applied over
AoAC revealed by CXR as shown in Figure 1. The number of
sectors occupied by AoAC, ranging from 0 to 16, were
recorded as AoAC score (AoACS). Two radiologists, both
specializing in CXR, independently reviewed these im-
ages. The images of 80 patients were reassessed by these
two radiologists because of interreader variability. Among
these 80 images, 19 images were initially scored 0 by only
one radiologist. Among the remaining 61 images, 46 im-
ages had initial scores varying 2.
AoAC extent was divided into four grades: Grade 0,
AoACSZ 0; Grade 1, AoACSZ 1e4; Grade 2, AoACSZ 5e8;
and Grade 3, AoACS Z 9e16.
Demographic and clinical data collection
All the data were collected in October 2006. Patients’ age,
sex, body height (BH), body weight (BW), systolic blood
pressure, diastolic blood pressure (DBP), diabetes mellitus
(DM), peritoneal equilibrium test, and dialysis adequacy
indices, including peritoneal urea clearance (Kt/V), renal
Kt/V, total Kt/V (the sum of peritoneal and renal Kt/Vs),
and standardized total weekly creatinine clearance, were
recorded. Duration of PD was defined as the interval be-
tween the initiation of PD and the time when CXR was
performed. CV disease (CVD) was defined as a history of
coronary artery disease, cerebrovascular accident, or pe-
ripheral arterial occlusive disease. Coronary artery diseasecalcification predicts mortality in patients undergoing peritoneal
x.doi.org/10.1016/j.jfma.2016.06.006
Figure 1 Measurement of the aortic arch calcification score
(AoACS) using plain chest radiography. A scale, divided into 16
circumferences, was attached to AoAC on the chest radio-
graph. In this example, the sectors occupied with AoAC are
marked by arrows. AoACS was recorded as 6.
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onary arterial bypass grafts, or confirmation by coronary
angiography. Cerebrovascular accident was defined as a
history of transient ischemic attack or stroke, and periph-
eral arterial occlusive disease was defined as a history of
claudication, ischemic limb loss, ulceration, or peripheral
revascularization. Laboratory data included levels of blood
hemoglobin, serum albumin, alkaline phosphatase, cal-
cium, phosphorus, total cholesterol, triglyceride, high-
density lipoprotein-cholesterol (HDL), low-density lipopro-
tein-cholesterol, intact parathyroid hormone, and ferritin.
Body mass index (BW/BH2), mean blood pressure (MBP),
and calciumephosphorus product (CPP) were calculated for
subsequent analyses.
Follow-up for endpoints
All enrolled patients were regularly followed up at the PD
clinic until September 2014. Time and causes of mortality
of patients were determined carefully by both chart review
and interviews with primary care nurses. Mortality due to
CV events was considered as death from myocardial
infarction, congestive heart failure, sudden cardiac death,
cardiac arrhythmia, or stroke. Nonfatal CV events requiring
hospitalization included acute coronary syndrome with or
without evidence of myocardial infarction, arrhythmia,
stroke or transient ischemic attack, and critical limb
ischemia.
Statistical analysis
The data were analyzed using the SAS software, Version 9.1
(SAS Institute Inc., Cary, NC, USA). A p value of <0.05 was
considered statistically significant. Continuous variables
were expressed as mean  standard deviation, and cate-
gorical variables were expressed as number, percentage.Please cite this article in press as: Wu C-F, et al., Severe aortic arch
dialysis, Journal of the Formosan Medical Association (2016), http://dTrend test was used to compare data between groups.
Multivariate regression analysis with stepwise variable se-
lection was used to determine the associated factors of
AoAC. Variables with p < 0.05 in the trend test were
selected. Then the stepwise procedure was applied to
select variables with both significance level for entry and
significance level for stay set to 0.15.
The KaplaneMeier survival curves were drawn, and
between-group survival was compared using the log-rank
test. Factors that predicted all-cause and CV mortalities
were determined with the Cox proportional hazard model.
Age, sex, duration of PD, DM status, history of CVD, and
MBP were included as variables first, and then stepwise
procedure was applied to select remaining variables with
both significance level for entry and significance level for
stay set to 0.15.
Results
Comparison of baseline clinical data between
patients with different grades of AoAC
The baseline characteristics of these 190 patients are
shown in Table 1. The mean age was 52.6  14.3 years, and
85 patients (44.7%) were men. They had received PD for
39  38 months on average. Only 29 patients (15.3%) had
DM, and 21 patients (11.1%) developed ESRD due to DM
nephropathy. Moreover, 40 patients (21.1%) had a history of
CVD.
According to the severity of AoAC, these patients were
divided into four groups: Grade 0 (80, 42.1%), Grade 1 (47,
24.7%), Grade 2 (36, 18.9%), and Grade 3 (27, 14.2%). As
shown in Table 1, patients with higher grades of AoAC were
older (p < 0.001), received longer duration of PD
(p Z 0.01), had lower MBP (p < 0.001), DBP (p < 0.001),
serum P (p Z 0.029), HDL (p Z 0.029), renal Kt/V
(p Z 0.037), and CPP (p Z 0.039), as well as higher serum
ferritin (p Z 0.01). In addition, higher prevalence rates of
DM (pZ 0.008) and CVD (p < 0.001) were found in patients
with higher grades of AoAC.
Factors associated with AoAC severity
In order to determine the associated factors of AoAC
severity in these patients, multiple regression analysis was
performed. As shown in Table 2, age (p < 0.001), duration
of PD (p Z 0.004) and history of CVD (p < 0.001) were in-
dependent factors positively associated with AoACS,
whereas renal Kt/V (p Z 0.031) was another independent
factor negatively associated with AoACS.
Because abdominal aortic calcification has been shown
to be positively correlated with left ventricular diastolic
dysfunction,11 we evaluated if there was any correlation
between AoAC and cardiac dysfunction. Only 81 enrolled
patients had echocardiographic reports available between
2005 and 2007. There was no association between grading
of AoAC and abnormal echocardiographic findings such as
left atrial dilation, left ventricular dilation, left ventricu-
lar hypertrophy, poor/impaired left ventricular contrac-
tility, and probable left ventricular diastolic dysfunction
(Table S1).calcification predicts mortality in patients undergoing peritoneal
x.doi.org/10.1016/j.jfma.2016.06.006
Table 1 Comparisons of baseline characteristics and clinical data among patients who underwent peritoneal dialysis with
different grades of aortic arch calcification using the trend test.
Variable All patients
(N Z 190)
Grading of Aortic Arch Calcification p Value of
trend test0
(N Z 80)
1
(N Z 47)
2
(N Z 36)
3
(N Z 27)
Age (y) 52.6  14.3 45.4  13.3 51.9  10.8 57.7  10.1 68.7  11.6 <0.001
Male (no. %) 85, 44.7 35, 43.8 19, 40.4 21, 58.3 10, 37.0 0.293
DM (no. %) 29, 15.3 10, 12.5 6, 12.8 3, 8.3 10, 37.0 0.008
Duration of PD (mo) 39.0  38 30.1  26 39.1  42 54.9  50.4 43.8  35.6 0.010
BMI (kg/m2) 22.7  3.5 22.9  3.9 22.5  3.3 22.8  3 22.5  3.2 0.914
MBP (mmHg) 98.0  10.5 100.8  10.7 98.4  9.6 96.3  8.9 91.3  10.8 <0.001
SBP (mmHg) 138.4  16.3 139.4  16.1 139.5  15.6 135.5  16.1 136.9  18.9 0.609
DBP (mmHg) 84.5  9.8 87.8  9.8 84.8  8.7 82.7  7.3 76.2  9.3 <0.001
Hb (g/dL) 9.8  1.5 9.7  1.5 9.9  1.4 10.1  1.8 9.6  1.3 0.446
Albumin (g/dL) 4.0  0.4 4.1  0.5 4.1  0.4 4.0  0.3 3.9  0.3 0.189
iPTH (mg/dL) 377.7  414.8 372.5  449 391.6  350.7 427.4  463.6 302.5  348.8 0.693
ALP (U/L) 200.9  115.1 212.8  122 174.2  94 194.8  102.1 220.6  138.8 0.234
Calcium (mg/dL) 9.4  0.9 9.2  1 9.4  0.9 9.5  0.8 9.5  0.6 0.274
P (mg/dL) 5.1  1.3 5.0  1.2 5.5  1.4 5.1  1.0 4.7  1.3 0.029
CPP (mg2/dL2) 48.0  13.3 46.1  12.7 52.4  14.7 48.7  11.2 44.9  13.3 0.039
Ferritin (ng/mL) 534.7  595.8 494.9  446.8 489.5  515.5 422  404.5 881.9  1063.8 0.010
TCHO (mg/dL) 201.1  47.1 195.5  39.8 212.4  48.1 205.1  51.1 192.4  57.3 0.169
LDL (mg/dL) 96.2  34.2 97.3  30.2 92.1  32.4 98.1  39.4 97.7  42.0 0.823
HDL (mg/dL) 42.4  10.5 43.4  11.5 44.9  10.3 39.9  9.2 38.6  7.2 0.029
TG (mg/dL) 192.2  148.3 162.6  113.8 217.7  202.3 222.3  143.8 195.6  123.4 0.108
H/HA PET (no. %) 64, 33.7 25, 31.3 15, 31.9 14, 38.9 10, 37.0 0.837
PKTV 2.0  0.4 2.0  0.4 1.9  0.4 2.0  0.4 2.1  0.3 0.155
RKTV 0.3  0.4 0.3  0.4 0.3  0.4 0.2  0.3 0.1  0.2 0.037
KTV 2.2  0.3 2.3  0.3 2.2  0.3 2.2  0.3 2.2  0.3 0.164
WCC 60.8  15.1 61.9  16.4 61.9  16.6 61.8  11.8 54.5  11.1 0.135
CAD (no. %) 29, 15.3 7, 8.8 4, 8.5 7, 19.4 11, 40.7 <0.001
PAOD (no. %) 8, 4.2 0, 0 0, 0 4, 11.1 4, 14.8 <0.001
CVA (no. %) 12, 6.3 1, 1.3 1, 2.1 2, 5.6 8, 29.6 <0.001
CVD (number, %) 40, 21.1 8, 10.0 5, 10.6 10, 27.8 17, 63.0 <0.001
ALP Z alkaline phosphatase; BMI Z body mass index; CAD Z coronary artery disease; CPP Z calciumephosphorus product;
CVA Z cerebrovascular accident; CVD Z cardiovascular diseases including CAD, PAOD, and CVA; DBP Z diastolic blood pressure;
DMZ diabetes mellitus; HA/H PETZ high average/high peritoneal equilibrium test; HbZ hemoglobin; HDLZ high-density lipoprotein
cholesterol; iPTHZ intact parathyroid hormone; KTVZ Kt/V; LDLZ low-density lipoprotein cholesterol; MBPZ mean blood pressure;
PZ phosphorus; PAODZ peripheral arterial occlusive disease; PDZ peritoneal dialysis; PKTVZ peritoneal Kt/V; RKTVZ renal Kt/V;
SBP Z systolic blood pressure; TCHO Z total cholesterol; TG Z triglyceride; WCC Z weekly creatinine clearance.
Table 2 Multiple regression analysis of association factors
for AoACS by stepwise variable selection method (NZ 190,
R2 Z 0.449).
Parameter estimate Standard error p
Intercept 0.727 3.220 0.822
Age 0.119 0.022 <0.001
CVD 2.873 0.634 <0.001
Duration
of PD
0.020 0.007 0.004
DBP 0.053 0.029 0.071
RKTV 1.694 0.780 0.031
AoACS Z aortic arch calcification score; CVD Z cardiovascular
diseases including coronary artery disease, peripheral arterial
occlusive disease, and cerebrovascular accident;
DBP Z diastolic blood pressure; PD Z peritoneal dialysis;
RKTV Z renal Kt/V.
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As vascular calcification has been shown to correlate with
CV morbidities,11,12 we wanted to know if there was any
association between CXR-detected AoAC and CVD. During
8 years of follow-up, 10 nonfatal CV events requiring hos-
pitalization were noted. As shown in Figure 2A, patients
with Grade 3 AoAC had lower CV event-free survival rate
than those with Grade 0 AoAC (log-rank test, p Z 0.002).
However, AoAC grading could not predict subsequent CV
events that required hospitalization in further multivariate
Cox regression analyses (data not shown).
AoAC grading as an independent risk factor for all-
cause and CV mortalities
During a mean follow-up period of 55.1  32.1 months, 47
patients (24.7%) died. Among them, 10 patients (21.3%)Please cite this article in press as: Wu C-F, et al., Severe aortic arch calcification predicts mortality in patients undergoing peritoneal
dialysis, Journal of the Formosan Medical Association (2016), http://dx.doi.org/10.1016/j.jfma.2016.06.006
Figure 2 KaplaneMeier analyses of (A) nonfatal cardiovascular (CV) events requiring hospitalization, (B) all-cause mortality, and
(C) CV mortality in 190 patients. (A) Patients with Grade 3 aortic arch calcification (AoAC) had lower CV event-free survival rate
than those with Grade 0 AoAC (log-rank test, pZ 0.002). (B) All-cause mortality was higher in patients with Grade 2 (log-rank test,
pZ 0.011) or Grade 3 (log-rank test, p < 0.001) AoAC than those with Grade 0 AoAC. (C) CV mortality was higher in patients with
severe AoAC (Grades 2 and 3 AoAC) than those with mild AoAC (Grade 0 and 1 AoAC) (log-rank test, p Z 0.013). G: grade.
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vival rates were 62.9% and 90.5%, respectively. Compared
with patients with Grade 0 AoAC, patients with Grade 2
(log-rank test, p Z 0.011) or Grade 3 (log-rank test,
p < 0.001) AoAC had higher all-cause mortality rate. In
addition, patients with Grades 2 and 3 AoAC had higher CV
mortality than those with Grades 0 and 1 AoAC (log-rank
test, p Z 0.013) (Figures 2B and 2C).
In order to determine if AoAC grading independently
predicted all-cause and CV mortalities, the multivariate
Cox proportional hazard model was used. Grade 2 AoAC
[hazard ratio (HR) Z 2.736; 95% confidence interval (CI),
1.038e7.211; p Z 0.042], Grade 3 AoAC (HR Z 3.289; 95%
CI, 1.156e9.359; p Z 0.026), and serum albumin levels
(HR Z 0.276; 95% CI, 0.114e0.673; p Z 0.005) correlated
independently with all-cause mortality after adjustment by
age, sex, DM status, MBP, and history of CVD (Table 3).
Similarly, severe AoAC including Grades 2 and 3 AoAC
(HR Z 36.05; 95% CI, 3.494e372.0; p Z 0.003), body mass
index (HR Z 13.56; 95% CI, 1.438e127.8; p Z 0.0023), and
serum albumin levels (HR Z 0.071; 95% CI, 0.009e0.533;
pZ 0.01) were independently associated with CV mortality
after adjustment by age, sex, DM status, MBP, and history of
CVD. Furthermore, CV mortality was negatively predicted
by age (HR Z 0.931; 95% CI, 0.875e0.990; p Z 0.024), but
was not predicted by history of CVD (Table 3).
Discussion
This prospective cohort study was designed to identify the
clinical significance of CXR-detected AoAC in patients
undergoing PD. We demonstrated that age, PD duration,
previous CVD, and renal Kt/V were independently asso-
ciated with AoAC. Other significant factors associated
univariately with AoAC were DM, DBP, serum P, ferritin,
and HDL. Moreover, severe AoAC predicted all-cause and
CV mortalities in patients who underwent PD after
adjustment by age, sex, PD duration, DM, and CVD
history.
Our study has shown that residual renal function (RRF)
decline correlates with vascular calcification in patients
who underwent PD, which is in agreement with previous
studies.22,23 This correlation is probably because of thePlease cite this article in press as: Wu C-F, et al., Severe aortic arch
dialysis, Journal of the Formosan Medical Association (2016), http://dincreased serum indoxyl sulfate levels as patients under-
going PD lose their RRF gradually.24 Given that indoxyl
sulfate can cause aortic calcification,25 patients undergoing
PD with decreased RRF have higher levels of indoxyl sul-
fate, resulting in progression of aortic calcification.
Therefore, interventions to lower indoxyl sulfate in pa-
tients undergoing PD might delay the progression of aortic
calcification.
Arterial stiffness is common in patients with chronic
kidney disease. Arterial stiffness involving the aorta leads
to an increase in systolic blood pressure and a decrease in
DBP; hence, it increases pulse pressure. Its severity can also
be evaluated by pulse wave velocity.26 In patients under-
going HD, both pulse pressure and pulse wave velocity have
been positively associated with AoAC.21,27 Our study also
demonstrates that in patients undergoing PD, DBP was
negatively associated with AoAC; this indicates that AoAC in
the dialysis population was strongly correlated with aortic
stiffness. This is probably because AoAC in the setting of
renal dysfunction is mainly composed of calcified medial
vasculopathy, which is known to induce arterial stiffness.28
Therefore, AoAC detected by CXR can be considered a
marker of aortic stiffness in patients undergoing dialysis.
Inflammation, commonly evaluated by the serum C-
reactive protein levels, has been considered an important
risk factor of CV calcification in patients undergoing
PD.13,29e31 In our study, as serum C-reactive protein levels
were not available, serum ferritin levels were evaluated
instead to represent inflammation status. We showed that
the serum ferritin levels had a significant association with
CXR-detected AoAC. Furthermore, lower serum P and CPP
levels were also correlated with higher grades of AoAC.
Because our study population was characterized by well-
controlled CPP levels (<55 mg2/dL2), lower serum P levels
probably indicated a status of malnutrition, which is linked
to inflammation.
Although AoAC detected by CXR has been shown to
predict all-cause and CV mortalities in patients undergoing
HD,18e20 the significance of CXR-detected AoAC in patients
undergoing PD has just been elucidated. To our knowledge,
only one study showed that CXR-detected AoAC progression
could predict all-cause and CV mortalities in patients un-
dergoing PD. However, its mean follow-up time was lesscalcification predicts mortality in patients undergoing peritoneal
x.doi.org/10.1016/j.jfma.2016.06.006
Table 3 Factors predicting all-cause and cardiovascular mortalities in patients undergoing peritoneal dialysis using the Cox
model.
Variable Parameter estimate Standard error Hazard ratio 95% CI p
All-cause mortality
Age 0.019 0.018 1.019 0.984e1.055 0.296
Male 0.369 0.324 0.692 0.366e1.305 0.255
Duration of PD 0.001 0.003 1.001 0.995e1.007 0.721
DM 1.074 0.406 2.926 1.321e6.480 0.008
CVD 0.662 0.381 1.939 0.919e4.091 0.082
MBP 0.025 0.018 0.975 0.942e1.010 0.157
Grade 1 versus 0 0.059 0.494 1.061 0.403e2.796 0.904
Grade 2 versus 0 1.027 0.503 2.792 1.041e7.484 0.041
Grade 3 versus 0 1.254 0.547 3.506 1.200e10.24 0.022
Albumin 1.387 0.478 0.250 0.098e0.638 0.004
Ferritin 0.000360 0.000220 1.000 1.000e1.001 0.102
Cardiovascular mortality
Age 0.148 0.059 0.862 0.768e0.968 0.012
Male 0.910 1.028 0.402 0.054e3.018 0.376
Duration of PD 0.030 0.017 0.971 0.940e1.003 0.074
DM 3.695 1.159 40.26 4.156e390.1 0.001
CVD 0.997 0.919 2.711 0.447e16.43 0.278
MBP 0.071 0.050 0.931 0.844e1.027 0.155
Grade 2 þ 3 versus 0 þ 1 4.621 1.520 101.6 5.160e2000 0.002
BMI 2.894 1.228 18.06 1.627e200.5 0.019
Albumin 3.493 1.148 0.030 0.003e0.288 0.002
Phosphorus 0.629 0.345 1.876 0.954e3.691 0.068
HDL 0.070 0.045 0.932 0.854e1.018 0.120
BMIZ body mass index; CIZ confidence interval; CVDZ cardiovascular diseases including coronary artery disease, peripheral arterial
occlusive disease, and cerebrovascular accident; DM Z diabetes mellitus; HDL Z high-density lipoprotein cholesterol; MBP Z mean
blood pressure; PD Z peritoneal dialysis.
6 C.-F. Wu et al.
+ MODELthan 3 years (34.2  20.4 months).13 Our study confirms
that severe CXR-detected AoAC predicted all-cause and CV
mortalities in patients undergoing PD after adjustment by
age, sex, PD duration, DM, and CVD history. Moreover, the
mean follow-up period of our study was much longer
(55.1  32.1 months). Therefore, CXR-detected AoAC has a
significant prognostic value in predicting all-cause and CV
mortalities in patients undergoing PD.
History of CVD has been regarded as a risk factor for CV
mortality in patients undergoing PD.11,32 However, history
of CVD could not predict CV mortality in our population.
Because our population was characterized by lower preva-
lence of DM (15.3% vs. 34e47%),11,32 previous CVD (21.1%
vs. 22.4e35%),11,32 and CV mortality (21.3% of total death
vs. 43.3e50% of total death),11,32 most of the population
still have medial vasculopathy, which might not be clini-
cally diagnosed as CVD but could be clearly represented by
AoAC. Therefore, CXR-detected AoAC, not history of CVD,
dominated in predicting CV mortality in our population. It
indicates that AoAC could be a good marker in representing
medial vasculopathy especially in non-DM patients under-
going PD.
To conclude, our study shows that in addition to age and
PD duration, RRF and CV history were strongly associated
with CXR-detected AoAC in patients undergoing mainte-
nance PD. We also show with evidence that arterial stiff-
ness (represented by DBP) and inflammation (represented
by serum ferritin levels) had correlations with CXR-Please cite this article in press as: Wu C-F, et al., Severe aortic arch
dialysis, Journal of the Formosan Medical Association (2016), http://ddetected AoAC. Furthermore, we demonstrated that se-
vere AoAC predicted all-cause and CV mortalities in pa-
tients undergoing PD independent of age, sex, PD duration,
DM, and CVD history. Finally, we show that CXR could be
considered a valuable tool to evaluate AoAC in patients
undergoing PD.
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